Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

fos-jun conspiracy: implications for the cell.

I M Verma1, L J Ransone, J Visvader

  • 1Molecular Biology and Virology Laboratory, Salk Institute, San Diego, CA 92138.

Ciba Foundation Symposium
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of therapeutic targets for glioblastoma by network analysis.

Oncogene·2015
Same author

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.

Oncogene·2011
Same author

LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.

Oncogene·2009
Same author

NF-kappaB and the regulation of hematopoiesis.

Cell death and differentiation·2006
Same author

Nuclear factor (NF)-kappaB proteins: therapeutic targets.

Annals of the rheumatic diseases·2004
Same author

Opportunities for the use of lentiviral vectors in human gene therapy.

Current topics in microbiology and immunology·2002

The fos and jun proteins form a stable complex (AP-1) that binds DNA. The fos protein

Area of Science:

  • Molecular Biology
  • Oncogenesis
  • Transcription Factors

Background:

  • Nuclear oncoproteins fos and jun (AP-1) form stable heterodimers.
  • The leucine zipper domain is essential for heterodimer formation.
  • The AP-1 complex binds to specific DNA sequences with high affinity.

Purpose of the Study:

  • To investigate the roles of fos and jun protein domains in DNA binding.
  • To determine the contribution of the basic region to the transcriptional complex's DNA binding affinity.
  • To explore the potential of fos and jun mutants as dominant-negative regulators.

Main Methods:

  • Site-directed mutagenesis of fos and jun proteins, focusing on the leucine zipper and basic regions.
  • Analysis of protein complex formation and DNA binding affinity.

Related Experiment Videos

  • Assessment of dominant-negative effects of mutant proteins on normal fos cellular function.

    • Main Results:

    • Mutations in the leucine zipper domain did not affect heterodimer formation.
    • The basic region of fos is critical for determining DNA binding affinity.
    • Mutations in fos basic amino acids prevented DNA binding, even with wild-type jun.
    • Mutants in the basic regions of fos and jun can function as dominant-negative inhibitors.

    Conclusions:

    • Fos protein plays a dominant role in jun-fos DNA binding, despite lacking DNA binding capability alone.
    • The basic region of fos is crucial for high-affinity DNA binding of the AP-1 complex.
    • Engineered fos and jun mutants offer a strategy to inhibit normal fos function in cellular processes.